Merck Sharp & Dohme Corp. v. Aurobindo Pharma Limited et al
| Merck Sharp & Dohme Corp. |
| Aurobindo Pharma USA, Inc. and Aurobindo Pharma Limited |
| 1:2020cv00949 |
| July 15, 2020 |
| US District Court for the District of Delaware |
| Richard G Andrews |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. ยง 271 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on August 26, 2020. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 9 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Aurobindo Pharma Ltd. for Aurobindo Pharma USA, Inc. filed by Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc.. (Ormerod, Eve) |
| Filing 8 ANSWER to #1 Complaint, Additional Defenses, and COUNTERCLAIMS against Merck Sharp & Dohme Corp., by Aurobindo Pharma USA, Inc., Aurobindo Pharma Limited.(Ormerod, Eve) Modified on 8/27/2020 (nms). |
| Filing 7 STIPULATION TO EXTEND TIME to Answer, Move, or Otherwise Respond to Complaint to August 26, 2020 - filed by Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc.. (Ormerod, Eve) |
SO ORDERED, re #7 STIPULATION TO EXTEND TIME to Answer, Move, or Otherwise Respond to Complaint to August 26, 2020 (*Reset Answer Deadlines: Aurobindo Pharma Limited answer due 8/26/2020; Aurobindo Pharma USA, Inc. answer due 8/26/2020). Signed by Judge Richard G. Andrews on 8/20/2020. (nms)
|
| Filing 6 DECLARATION of Service regarding Defedants Aurobindo Pharma Limited and Aurobindo Pharma USA, Inc. made on July 23, 2020, by Merck Sharp & Dohme Corp.. (Joyce, Alexandra) Modified on 7/23/2020 (nms). |
| Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Merck & Co., Inc. for Merck Sharp & Dohme Corp. filed by Merck Sharp & Dohme Corp. (sam) |
| Filing 4 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 06/10/2020. Date of Expiration of Patent: 11/24/2026.Thirty Month Stay Deadline: 12/10/2022. (sam) |
| Filing 3 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,326,708. (sam) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (sam) |
| Filing 1 COMPLAINT filed against Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number ADEDC-3063422.)- filed by Merck Sharp & Dohme Corp. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet)(sam) |
| No Summons Issued. (sam) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
